Last 24 hours to grab your +1 pass at 50% off to TechCrunch Disrupt 2026

Today is the last day to lock in a +1 pass at 50% off to TechCrunch Disrupt 2026, happening on October 13-15 in San Francisco. Register here.

TechCrunch Disrupt 2026: Plus-one passes are almost gone and only 3 days remain

The TechCrunch Disrupt 2026 plus-one passes at 50% off are almost sold out, and this deal ends in 3 days. Register here before this deal ends on Friday, January 30 at 11:59 p.m. PT.

The conference where founders scale: TechCrunch Founder Summit 2026 tickets are now live at the lowest prices

TechCrunch Founder Summit 2026 unites 1,100 founders and investors in Boston on June 23 for a day focused on real-world scaling insights and networking that pushes the needle. Save up to $300 on your ticket.

South Korea’s Edenlux set for U.S. debut of eye-strain wellness device

Edenlux builds wearable tech to protect and train your eyes, inspired by its founder’s personal vision recovery.

Obvious Ventures lands fund five with a 360-degree view of planetary, human, economic health

The 12-year-old firm raised $360,360,360 for its fifth fund. And there’s a reason for that number.

Only 5 days left: Over half of the first 500 TechCrunch Disrupt 2026 +1 passes at 50% off are already gone

Register now to save up to $680 on your TechCrunch Disrupt 2026 pass and get a +1 ticket at 50% off. Offer ends this Friday, January 30.

Only 1 week left (or until the first 500 passes are gone): The first TechCrunch Disrupt 2026 ticket discount is ending 

Register now to save up to $680 on your TechCrunch Disrupt 2026 pass and get a second ticket at 50% off. This offer ends next week on January 30, or once the first 500 tickets are claimed — whichever comes first.

OpenEvidence hits $12B valuation, with new round led by Thrive, DST  

The medical info database has doubled in valuation since last raise in October, despite encroachment from model makers.

Why Serve Robotics is acquiring a hospital assistant robot company

Diligent Robotics is a startup that builds robots designed to assist in hospitals by delivering lab samples, supplies, and other tasks. The deal values Diligent’s common stock at $29 million.

Biotics AI, Battlefield 2023, gains FDA approval for its AI-powered fetal ultrasound product 

TechCrunch Disrupt Battlefield 2023 winner, Biotics AI, announced on Monday that it has received FDA clearance for its AI software that helps detect fetal abnormalities in ultrasound images.